rosiglitazone has been researched along with gkt137831 in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Green, DE; Hart, CM; Kang, BY; Kleinhenz, JM; Murphy, TC; Page, P; Sutliff, RL; Szyndralewiez, C | 1 |
1 other study(ies) available for rosiglitazone and gkt137831
Article | Year |
---|---|
The Nox4 inhibitor GKT137831 attenuates hypoxia-induced pulmonary vascular cell proliferation.
Topics: Animals; Cell Hypoxia; Cell Proliferation; Cells, Cultured; Endothelial Cells; Endothelium, Vascular; Gene Expression; Gene Knockdown Techniques; Humans; Hydrogen Peroxide; Hypertension, Pulmonary; Lung; Mice; Mice, Inbred C57BL; Myocytes, Smooth Muscle; NADPH Oxidase 4; NADPH Oxidases; PPAR gamma; Proliferating Cell Nuclear Antigen; Pulmonary Artery; Pyrazoles; Pyrazolones; Pyridines; Pyridones; RNA Interference; Rosiglitazone; Thiazolidinediones; Transforming Growth Factor beta1; Ventricular Remodeling | 2012 |